The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
Bibliographic Information
- Title
- The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
- Author
- Tsutomu Murakami
Journal
-
- Antimicrobial Agents and Chemotherapy 53(7)
-
Antimicrobial Agents and Chemotherapy 53(7) 2940-2948, 2009
- Tweet
Details 詳細情報について
-
- CRID
- 1010282257024441481
-
- Article Type
- journal article
-
- Data Source
-
- KAKEN